NanoViricides Inc (NNVC)

[drkazmd65]

From a recent Proactive article on NNVC dated 2/19/2026 linked on NNVC's corporate website:

https://www.proactiveinvestors.com/companies/news/1087630/nanoviricides-advances-toward-fully-funded-phase-ii-mpox-trial-in-drc.html

"Dr. Diwan said the company is advancing NV-387—a novel broad-spectrum antiviral that represents a new class of antiviral drugs—toward a Phase II clinical trial. NanoViricides is preparing to initiate a Phase II human study to evaluate the safety and effectiveness of NV-387 as a treatment for MPox in the Democratic Republic of Congo (DRC).

The local regulatory authority, ACOREP, has already approved the Phase II clinical trial, subject to the completion of certain remaining requirements. The company reported that most of these conditions have been satisfied and is now focused on final site readiness and documentation necessary to formally launch the trial. Management stated that current funding is sufficient to execute and complete the planned Phase II study in the DRC according to its projections."

Maybe it will actually 'happen" for once and they will test NV-387 on an actual set of sick patients? Maybe some actual human efficacy data will be generated?